BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 1, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 3, 2017
View Archived Issues
CytomX Therapeutics advances CX-2029, reaching milestone in AbbVie collaboration
Read More
New phase I trial explores BI-754111 alone or in combination with BI-754091 in advanced cancer
Read More
Atridia conducts phase I study of SHR-1316 in patients with cancer
Read More
Patient enrollment begins in phase I/II study of AGTC-402
Read More
Pelican Therapeutics makes progress advancing PTX-25
Read More
European Commission approves Pfizer's inotuzumab ozogamicin
Read More
Clinical activity of larotrectinib may lead to NDA this year
Read More
Arthrogen begins phase I trial of ART-I02 in rheumatoid arthritis and active arthritis in the joint
Read More
AEterna Zentaris resubmits Macrilen NDA to FDA
Read More
TAS-120 shows promise for the treatment of FGFR-aberrant cholangiocarcinoma
Read More
Daiichi Sankyo reports topline results from NEUCOURSE and ALDAY studies of mirogabalin
Read More
TissueGene receives grant to support development of tonogenchoncel-L
Read More
TRX-818 well tolerated in phase I studies in patients with advanced cancer
Read More
Novel antibacterials patented by Fondazione Istituto Insubrico Ricerca per la Vita
Read More
FDA gives ibalizumab BLA priority review
Read More
TriMix-MEL begins phase Ib adjuvant melanoma trial
Read More
FDA approves Triptodur for central precocious puberty
Read More
Zealand initiates phase III trial of dasiglucagon to treat severe hypoglycemia in diabetes
Read More
Auspherix discovers antibacterial gold complexes
Read More
National Eye Institute funds research into dry eye
Read More
Merck & Co. identifies new muscarinic acetylcholine M1receptor modulators
Read More
Shanghai SIMR Biotech identifies new GABA(A) receptor subunit alpha-5 inverse agonists
Read More
Somatuline approved in Japan for gastroenteropancreatic neuroendocrine tumors
Read More
Roche discovers new gamma-secretase inhibitors
Read More
Exscientia collaborates with GSK on drug discovery
Read More
Spotlight Innovation enters sponsored research agreement with Brigham and Women's Hospital on SMA
Read More
AstraZeneca completes divestiture of Zomig to Grunenthal
Read More
SteadyMed submits NDA for Trevyent for PAH
Read More
BGB-290 combined with BGB-A317 in solid tumors trial
Read More
